212 related articles for article (PubMed ID: 32830997)
1. A Dual Enzyme-Based Biochemical Test Rapidly Detects Third-Generation Cephalosporin-Resistant CTX-M-Producing Uropathogens in Clinical Urine Samples.
Tarlton NJ; Petrovic DF; Frazee BW; Borges CA; Pham EM; Milton AK; Jackson N; deBoer TR; Murthy N; Riley LW
Microb Drug Resist; 2021 Apr; 27(4):450-461. PubMed ID: 32830997
[TBL] [Abstract][Full Text] [Related]
2. Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).
Rajivgandhi G; Maruthupandy M; Manoharan N
Microb Pathog; 2018 Aug; 121():123-130. PubMed ID: 29778819
[TBL] [Abstract][Full Text] [Related]
3. Extended-spectrum β-lactamase- producing gram-negative bacterial infections in severely ill COVID-19 patients admitted in a national referral hospital, Kenya.
Mutua JM; Njeru JM; Musyoki AM
Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):91. PubMed ID: 37838665
[TBL] [Abstract][Full Text] [Related]
4. Utility of the MBT STAR-Cepha kit in detecting extended-spectrum β-lactamase producers in clinical urine samples and positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Ota Y; Furuhashi K; Hirai N; Nagao Y; Ishikawa J; Nagura O; Yamashita K; Maekawa M
J Microbiol Methods; 2023 Aug; 211():106756. PubMed ID: 37285970
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population.
Eltai NO; Al Thani AA; Al-Ansari K; Deshmukh AS; Wehedy E; Al-Hadidi SH; Yassine HM
Antimicrob Resist Infect Control; 2018; 7():90. PubMed ID: 30069306
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013.
Jean SS; Coombs G; Ling T; Balaji V; Rodrigues C; Mikamo H; Kim MJ; Rajasekaram DG; Mendoza M; Tan TY; Kiratisin P; Ni Y; Weinman B; Xu Y; Hsueh PR
Int J Antimicrob Agents; 2016 Apr; 47(4):328-34. PubMed ID: 27005459
[TBL] [Abstract][Full Text] [Related]
7. A rapid, antibiotic susceptibility test for multidrug-resistant, Gram-negative bacterial uropathogens using the biochemical assay, DETECT.
Jackson N; Borges CA; Tarlton NJ; Resendez A; Milton AK; de Boer TR; Butcher CR; Murthy N; Riley LW
J Microbiol Methods; 2021 Mar; 182():106160. PubMed ID: 33548393
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania.
McGettigan SE; Hu B; Andreacchio K; Nachamkin I; Edelstein PH
J Clin Microbiol; 2009 Sep; 47(9):2970-4. PubMed ID: 19587301
[TBL] [Abstract][Full Text] [Related]
10. High burden of ESBL- producing Klebsiella spp., Proteus mirabilis, Enterobacter cloacae and Pseudomonas aeruginosa in diagnosed cases of urinary tract infection in a Nigerian Teaching Hospital.
Adekanmbi AO; Akinlabi OC; Usidamen S; Olaposi AV; Olaniyan AB
Acta Microbiol Immunol Hung; 2022 Jun; 69(2):127-134. PubMed ID: 35895567
[TBL] [Abstract][Full Text] [Related]
11. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Martinez P; Garzón D; Mattar S
Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of CTX-M
Koirala S; Khadka S; Sapkota S; Sharma S; Khanal S; Thapa A; Khadka DK; Poudel P
Biomed Res Int; 2021; 2021():9958294. PubMed ID: 34212045
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
14. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance and extended-spectrum beta-lactamase producing Gram-negative bacteria from three Referral Hospitals of Amhara region, Ethiopia.
Moges F; Gizachew M; Dagnew M; Amare A; Sharew B; Eshetie S; Abebe W; Million Y; Feleke T; Tiruneh M
Ann Clin Microbiol Antimicrob; 2021 Mar; 20(1):16. PubMed ID: 33706775
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.
Vlieghe ER; Huang TD; Phe T; Bogaerts P; Berhin C; De Smet B; Peetermans WE; Jacobs JA; Glupczynski Y
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1223-9. PubMed ID: 25717021
[TBL] [Abstract][Full Text] [Related]
17. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
[TBL] [Abstract][Full Text] [Related]
18. [Species composition and molecular-genetic characteristics of antibiotic-resistant strains of gram negative bacteria isolated from patients of a hospitals urology department].
Shalekenov BU; Bissekenova AL; Ramazanova BA; Adambekov DA; Shalekenov SB
Urologiia; 2018 Mar; (1):77-83. PubMed ID: 29634138
[TBL] [Abstract][Full Text] [Related]
19. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of Extended-spectrum β lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt.
Hassuna NA; Khairalla AS; Farahat EM; Hammad AM; Abdel-Fattah M
Sci Rep; 2020 Feb; 10(1):2772. PubMed ID: 32066805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
